Clinical Trial Update: Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC) [Phase 2]

View source ↗

Summary

Phase 2 trial of DKN-01 plus nivolumab in advanced biliary tract cancer has been terminated; results were posted on 2024-04-10.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• DKN-01 (dkn-01)
• nivolumab (nivolumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Biliary Tract Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-04-10